Ultrasound-guided leukocytes-poor platelet-rich plasma injection for lateral epicondylitis, a randomized, double-blinded, controlled trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900024425

Enrollment

Unknown

Registered

2019-07-11

Start date

2019-09-01

Completion date

Unknown

Last updated

2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lateral epicondylitis

Interventions

Leukocyte-poor PRP group:Leukocyte-poor-platelet-rich plasma

NS group:saline solution

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Diagnosed with lateral epicondylitis over 3 months, suffering from pain with VAS (visual analog scale) >= 5, aged 18 to 65 years, ultrasonographic confirmation of lateral epicondylitis.

Exclusion criteria

Exclusion criteria: Patients with immune system diseases or neurological disorders, such as cervical radiculopathy or carpal tunnel syndrome, peripheral nerve injury; affected upper arm with elbow or wrist fractures; patients with a history of elbow surgery; taking oral NSAIDs medication within last 2 weeks or local steroid injections within last 6 weeks; patients with history of allergy reaction, cardiopulmonary insufficiency, thrombocytopenia or other coagulation disorder; pregnant females; patients with tumor or those who can complete this trial.

Design outcomes

Primary

Measure	Time frame
ASES score;	—

Secondary

Measure	Time frame
Quick DASH (Disabilities of the Arm, Shoulder, Hand);VAS score;	—

Countries

China

Contacts

Public ContactHe Hongchen

West China Hospital, Sichuan University

912606137@qq.com+86 18980602262

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026